Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma

Manali Kamdar, Hongli Li, Robert W. Chen, Lisa M. Rimsza, Michael L. Leblanc, Timothy S. Fenske, Thomas C. Shea, Paul M. Barr, Tycel J. Phillips, John P. Leonard, Brad S. Kahl, Jonathan W. Friedberg, Sonali M. Smith

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)3132-3135
Number of pages4
JournalBlood Advances
Volume3
Issue number20
DOIs
StatePublished - Oct 22 2019

Fingerprint

Mantle-Cell Lymphoma
Outcome Assessment (Health Care)
Transplants
Bendamustine Hydrochloride

ASJC Scopus subject areas

  • Hematology

Cite this

Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma. / Kamdar, Manali; Li, Hongli; Chen, Robert W.; Rimsza, Lisa M.; Leblanc, Michael L.; Fenske, Timothy S.; Shea, Thomas C.; Barr, Paul M.; Phillips, Tycel J.; Leonard, John P.; Kahl, Brad S.; Friedberg, Jonathan W.; Smith, Sonali M.

In: Blood Advances, Vol. 3, No. 20, 22.10.2019, p. 3132-3135.

Research output: Contribution to journalArticle

Kamdar, M, Li, H, Chen, RW, Rimsza, LM, Leblanc, ML, Fenske, TS, Shea, TC, Barr, PM, Phillips, TJ, Leonard, JP, Kahl, BS, Friedberg, JW & Smith, SM 2019, 'Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma', Blood Advances, vol. 3, no. 20, pp. 3132-3135. https://doi.org/10.1182/bloodadvances.2019000526
Kamdar, Manali ; Li, Hongli ; Chen, Robert W. ; Rimsza, Lisa M. ; Leblanc, Michael L. ; Fenske, Timothy S. ; Shea, Thomas C. ; Barr, Paul M. ; Phillips, Tycel J. ; Leonard, John P. ; Kahl, Brad S. ; Friedberg, Jonathan W. ; Smith, Sonali M. / Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma. In: Blood Advances. 2019 ; Vol. 3, No. 20. pp. 3132-3135.
@article{6eb2506a1fda400d87e535ac73cfdf33,
title = "Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma",
author = "Manali Kamdar and Hongli Li and Chen, {Robert W.} and Rimsza, {Lisa M.} and Leblanc, {Michael L.} and Fenske, {Timothy S.} and Shea, {Thomas C.} and Barr, {Paul M.} and Phillips, {Tycel J.} and Leonard, {John P.} and Kahl, {Brad S.} and Friedberg, {Jonathan W.} and Smith, {Sonali M.}",
year = "2019",
month = "10",
day = "22",
doi = "10.1182/bloodadvances.2019000526",
language = "English (US)",
volume = "3",
pages = "3132--3135",
journal = "Blood advances",
issn = "2473-9529",
publisher = "American Society of Hematology",
number = "20",

}

TY - JOUR

T1 - Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma

AU - Kamdar, Manali

AU - Li, Hongli

AU - Chen, Robert W.

AU - Rimsza, Lisa M.

AU - Leblanc, Michael L.

AU - Fenske, Timothy S.

AU - Shea, Thomas C.

AU - Barr, Paul M.

AU - Phillips, Tycel J.

AU - Leonard, John P.

AU - Kahl, Brad S.

AU - Friedberg, Jonathan W.

AU - Smith, Sonali M.

PY - 2019/10/22

Y1 - 2019/10/22

UR - http://www.scopus.com/inward/record.url?scp=85074915718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074915718&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2019000526

DO - 10.1182/bloodadvances.2019000526

M3 - Article

C2 - 31648328

AN - SCOPUS:85074915718

VL - 3

SP - 3132

EP - 3135

JO - Blood advances

JF - Blood advances

SN - 2473-9529

IS - 20

ER -